Administration of combined vincristine and prednisone is associated with more rapid increase in platelet numbers and shortened duration of hospitalization in dogs with IMT, compared with use of prednisone alone. Early use of vincristine seems warranted in dogs with severe primary IMT.
Results suggest that a small percentage of dogs with cervical spinal disorders may require perioperative ventilatory support. With prolonged PPV and aggressive management, a good outcome may be achieved in dogs similar to those described in the present study.
Gastrointestinal foreign bodies occur commonly in dogs. The objective of the study was to describe the acid-base and electrolyte abnormalities identified in dogs with gastrointestinal foreign bodies and determine if these abnormalities are related to the site or type of foreign body present. Medical records of 138 dogs were reviewed, and information on signalment, initial venous electrolyte and acid-base values, surgical findings, relevant historical information, imaging modalities used, cost of hospital visit, intra-or postoperative complications, and survival was obtained. The site of the foreign body was recorded in 94.9% of cases and the most common site was the stomach (50%), followed by the jejunum (27.5%). The foreign bodies were linear in 36.2% of cases. The most common electrolyte and acid-base abnormalities regardless of the site or type of foreign body were hypochloremia (51.2%), metabolic alkalosis (45.2%), hypokalemia (25%), and hyponatremia (20.5%). No significant association was found between electrolyte or acid-base abnormalities and the site of foreign body. Linear, as opposed to discrete, foreign bodies were more likely to be associated with a low serum sodium concentration (odds ratio, 0.85; 95% confidence interval, 0.75-0.95). Hyperlactatemia (Ͼ2.4 mmol/L) was seen in 40.5% of dogs. A wide variety of electrolyte and acid-base derangements are found in dogs with gastrointestinal foreign bodies. Hypochloremia and metabolic alkalosis are common in these dogs. Hypochloremic, hypokalemic metabolic alkalosis is seen with both proximal and distal gastrointestinal foreign bodies.Key words: Alkalosis; Hypochloremia; Hypokalemia; Hyponatremia; Linear. Dogs with clinical signs resulting from gastrointestinal foreign bodies are common in small-animal veterinary practice.1 Dogs ingest a large variety of objects that either pass through the gastrointestinal (GI) tract or cause a complete or partial obstruction. Other ingested objects act as linear foreign bodies and cause plication of the small intestine.2 Animals with GI disease frequently have acid-base and electrolyte abnormalities.3 Large volumes of fluid and electrolytes are secreted and reabsorbed by the healthy GI tract daily. In a 20-kg dog, approximately 2.5 L of fluid enters the GI tract from diet and normal gastrointestinal secretions and over 98% is reabsorbed daily. 4 Experimental studies of GI obstruction in dogs have revealed that, after an obstruction has been present for over 24 hours, there is secretion of sodium, potassium, and water rather than absorption in the bowel proximal to the obstruction. Gastrointestinal function is also abnormal distal to the obstruction. 5 Thus, disturbances in normal GI tract function secondary to complete or partial obstruction can rapidly result in disturbances of fluid balance, acid-base status, and serum electrolyte concentrations. Protracted or profuse vomiting and diarrhea with reluctance to consume adequate volumes of food and fluid can also affect the intravascular volume and hydration
Vascular endothelial growth factor (VEGF) is a dimeric glycosylated polypeptide growth factor with potent angiogenic, mitogenic, and vascular permeability-enhancing properties specific for endothelial cells. In humans, VEGF seems to play a major role in tumor growth, and plasma concentrations correlate with tumor burden, response to therapy, and disease progression. This study compared plasma VEGF concentrations in healthy client-owned dogs (n = 17) to dogs with hemangiosarcoma (HSA; n 16). Dogs with HSA were significantly more likely to have detectable concentrations of plasma VEGF (13/17) compared to healthy dogs (1/17; P < .001). The median plasma VEGF concentration for dogs with HSA was 17.2 pg/mL (range, < 1.0-66.7 pg/mL). Plasma VEGF concentrations in dogs with HSA did not correlate with stage of disease or tumor burden, but 1 dog had undetectable VEGF during chemotherapy that subsequently increased with disease progression.
Objective To conduct a narrative review of the current literature in reference to the structure and function of the endothelial glycocalyx (EG) and its contribution to the pathophysiology of conditions relevant to the veterinary emergency and critical care clinician. Novel therapies for restoring or preserving the EG will also be discussed. Data Sources Online databases (PubMed, CAB abstracts, Scopus) were searched between January 1st 2017 and May 1st 2017 for English language articles without publication date restriction. Keywords included EG, endothelial surface layer, degradation, syndecan‐1, heparan sulfate, critical illness, sepsis, trauma, and therapeutics. Data Synthesis The EG is a complex and important structure located on the luminal surface of all blood vessels throughout the body. It plays an important role in normal vascular homeostasis including control of fluid exchange across the vascular barrier. Loss or degradation of the EG has an impact on inflammation, coagulation, and vascular permeability and tone. These changes are essential components in the pathophysiology of many conditions including sepsis and trauma. A substantial body of experimental animal and human clinical research over the last decade has demonstrated increased circulating concentrations of EG degradation products in these conditions. However, veterinary‐specific research into the EG and critical illness is currently lacking. The utility of EG degradation products as diagnostic and prognostic tools continues to be investigated and new therapies to preserve or improve EG structure and function are under development. Conclusions The recognition of the presence of the EG has changed our understanding of transvascular fluid flux and the pathophysiology of many conditions of critical illness. The EG is an exciting target for novel therapeutics to improve morbidity and mortality in conditions such as sepsis and trauma.
Objective: To review the principles and practice of cardiopulmonary cerebral resuscitation (CPCR) in veterinary medicine, and to incorporate recommendations from the human International Guidelines 2000 Conference on cardiopulmonary resuscitation and emergency cardiovascular care. Data sources: Both clinical and experimental studies from the human and veterinary literature were reviewed for this manuscript. Summary: Cardiopulmonary cerebral resuscitation consists of basic life support measures, advanced life support measures, and post-resuscitation care. Part I of this article introduced the evidence-based recommendations from human medicine and reviewed basic life support. Part II of this article reviews advanced life support, including drug therapy and electrical defibrillation based upon the electrocardiographic rhythm present at the time of cardiopulmonary arrest (CPA). Post-resuscitation care is discussed, with a particular focus on optimizing perfusion to the brain, kidneys, and gastrointestinal tract. Several currently investigational methods that may improve future patient outcomes are also addressed. Conclusions: Advanced life support techniques provide methods to augment CPCR efforts. As with basic life support, recent recommendations to improve advanced life support in humans may be also be applied to veterinary patients. However, clinical research evaluating these interventions in veterinary CPCR is necessary. Post-resuscitation care requires vigilant monitoring and aggressive support to ensure vital organ perfusion and maximize patient outcomes.(J Vet Emerg Crit Care 2003; 13(1): 13±23)
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.